Psychotropic prescriptions for the treatment of schizophrenia in an outpatient clinic.

about

Psychotropic prescriptions for the treatment of schizophrenia in an outpatient clinic.

Item

http://www.wikidata.org/entity/Q46564630

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Psychotropic prescriptions for the treatment of schizophrenia in an outpatient clinic.

@en

Psychotropic prescriptions for the treatment of schizophrenia in an outpatient clinic.

@nl

type

Item

label

Psychotropic prescriptions for the treatment of schizophrenia in an outpatient clinic.

@en

Psychotropic prescriptions for the treatment of schizophrenia in an outpatient clinic.

@nl

prefLabel

Psychotropic prescriptions for the treatment of schizophrenia in an outpatient clinic.

@en

Psychotropic prescriptions for the treatment of schizophrenia in an outpatient clinic.

@nl

P1476

Psychotropic prescriptions for the treatment of schizophrenia in an outpatient clinic.

@en

P2093

Christopher Izehinosen Okpataku

http://www.w3.org/2001/XMLSchema#string

David Tawani

http://www.w3.org/2001/XMLSchema#string

P2860

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Olanzapine: an updated review of its use in the management of schizophrenia.

Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample.

Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

The Mount Sinai conference on the pharmacotherapy of schizophrenia.

Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Influence of patients' socioeconomic status on clinical management decisions: a qualitative study.

P304

165-172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/2237-6089-2016-0088

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28876362

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia